About Pantson Pharma
Pantson Pharma is a Healthcare company based in Mumbai (India) founded in 2010. It operates as a pharmaceutical manufacturing, RD, and global distribution of medicines with a focus on quality and affordability. The company has 25 employees. Its Indian entity Pantson Pharma Private Limited reported revenue of ₹10.01 Cr. Pantson Pharma offers products and services including Finished Dosage Formulations and DC Granules and Pellets. Its focus areas include Pharmaceutical Services, Global Distribution, International Supply and Pharmaceuticals.
Company details
Pantson Pharma is identified as a pharmaceutical manufacturer that prioritizes research and development to produce cost-effective medicines aligned with global standards. Its operations are conducted across multiple continents, including Asia, C.I.S, Africa, and South America, where high-quality products are made accessible without compromise. Certifications such as WHO-GMP and ISO 9001 are maintained to ensure reliability and customer satisfaction. The company has been operational for over 12 years, focusing on therapeutic areas and innovative services. Contributions from its team are acknowledged for sustaining these efforts.
- Headquarters Mumbai, India
- Employees 25
- SectorsHealthcare
- Email••••••••
- Social LinkedIn Facebook
- Legal Name Pantson Pharma Private Limited
- Date of Incorporation 20 Sep, 2012
- Jurisdiction Thane, Maharashtra, India
- Annual Revenue₹10.01 Cr
FY 2024 · +12% YoY
- Net Profit₹50.2 Lakh
FY 2024 · 5% margin
- EBITDA₹1.36 Cr
FY 2024 · 14% margin
- Employee Count25
Associated legal entities of Pantson Pharma
Pantson Pharma operates through Pantson Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pantson Pharma Private Limited CIN U74120MH2012PTC235942 | Active | 20 Sep 2012 | Thane, Maharashtra | ₹10.0 Cr | 25 | 2 | View details |
Products & Services of Pantson Pharma
Pantson Pharma offers a comprehensive portfolio of products and services, including Finished Dosage Formulations and DC Granules and Pellets.
These formulations are produced by Pantson Pharma with a focus on research and development to meet high-quality standards for therapeutic use.
DC granules and pellets are developed by Pantson Pharma to support cost-effective and accessible pharmaceutical solutions in various therapeutic areas.
Board of directors of Pantson Pharma Private Limited (Pantson Pharma)
Pantson Pharma Private Limited is the primary company behind Pantson Pharma. The board of Pantson Pharma Private Limited currently have 2 directors; the longest-serving is Monica Pant, appointed in 2019. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Monica Pant DIN 08380165 | Director | 04 Mar 2019 | 7 yrs 7 mo | Pantson Pharma Private Limited |
| Urmila Devi Vemula DIN 06366248 | Director | 01 Jul 2021 | 5 yrs 3 mo | Pantson Pharma Private Limited |
Financials of Pantson Pharma
Figures of Pantson Pharma Private Limited, the primary company behind Pantson Pharma, for FY 2024. Revenue was ₹10.01 Cr (+12% year on year). Net profit was ₹50.2 Lakh (5% margin). EBITDA was ₹1.36 Cr (14% margin). Revenue has grown at a compounded annual rate of +41% over three years and +30% over five years.
- ₹10.01 CrRevenue · FY 2024 · +12% YoY
- ₹50.2 LakhNet profit · 5% margin
- ₹1.36 CrEBITDA · 14% margin
- ₹1 LakhPaid-up capital
- 25Employees (provident fund records)
- +41%Revenue CAGR, 3 years
- +30%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Pantson Pharma Private Limited are on its company page.
Detailed financial statements for Pantson Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Pantson Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pantson Pharma
Pantson Pharma was founded in 2010.
Pantson Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Pantson Pharma has 25 employees.
The primary company behind Pantson Pharma, Pantson Pharma Private Limited, reported revenue of ₹10.01 Cr for FY 2024, up 12% year on year.
Pantson Pharma is identified as a pharmaceutical manufacturer that prioritizes research and development to produce cost-effective medicines aligned with global standards. Its operations are conducted across multiple continents, including Asia, C.I.S, Africa, and South America, where high-quality products are made accessible without compromise. Certifications such as WHO-GMP and ISO 9001 are maintained to ensure reliability and customer satisfaction. The company has been operational for over 12 years, focusing on therapeutic areas and innovative services. Contributions from its team are acknowledged for sustaining these efforts.
Pantson Pharma offers Finished Dosage Formulations and DC Granules and Pellets.
Pantson Pharma operates through Pantson Pharma Private Limited.
The legal entities of Pantson Pharma currently have 2 directors, including Monica Pant, Urmila Devi Vemula.